Anoro Ellipta recalls
Anoro Ellipta products have been recalled 1 time, most recently on 3 Jan 2024. The recalling company is usually GlaxoSmithKline. The most common reason is potency & assay.
Total recalls1since 2024
Last 12 months0reported
Class I00% of total
Ongoing0latest 3 Jan 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 1 100%
Why anoro ellipta is recalled
Companies
Product types
By year
All anoro ellipta recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Anoro Ellipta (umeclidinium recalled by GlaxoSmithKlineAnoro Ellipta | GlaxoSmithKline | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.